Qube Research & Technologies (QRT)’s Amgen AMGN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$37.2M	Sell	105,700 -75,700	-42%	-$27M	0.04%	549
2025 Q4	$59.4M	Sell	181,400 -5,900	-3%	-$1.87M	0.06%	419
2025 Q3	$52.9M	Buy	187,300 +17,600	+10%	+$5.1M	0.05%	440
2025 Q2	$47.4M	Sell	169,700 -230,200	-58%	-$65.2M	0.05%	492
2025 Q1	$125M	Buy	399,900 +272,700	+214%	+$80.5M	0.14%	169
2024 Q4	$33.2M	Sell	127,200 -197,800	-61%	-$58.7M	0.04%	515
2024 Q3	$105M	Sell	325,000 -29,100	-8%	-$9.52M	0.15%	144
2024 Q2	$111M	Sell	354,100 -124,900	-26%	-$36.7M	0.17%	131
2024 Q1	$136M	Buy	479,000 +274,800	+135%	+$80.4M	0.22%	107
2023 Q4	$58.8M	Buy	204,200 +199,100	+3,904%	+$54.2M	0.11%	220
2023 Q3	$1.37M	Sell	5,100 -16,400	-76%	-$4.09M	﹤0.01%	1582
2023 Q2	$4.77M	Buy	+21,500	New	+$4.99M	0.02%	711

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AMGN Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Amgen (AMGN) stake by 1,763% in Q1 2026, buying an estimated $49.8M and bringing the position to 147,488 shares worth $51.9M. The position accounts for 0.06% of the portfolio, ranked #417.

Qube Research & Technologies (QRT) first reported a position in AMGN in Q1 2018 and has held it in 27 quarters since. The position peaked at $333M in Q4 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Qube Research & Technologies (QRT) held 147,488 shares of Amgen worth $51.9M as of Q1 2026.
Qube Research & Technologies (QRT) bought 139,570 Amgen shares in Q1 2026, an estimated $49.8M.
Amgen made up 0.06% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #417 holding.
Qube Research & Technologies (QRT) first reported a position in Amgen in Q1 2018 and has held it in 27 quarters since.
Qube Research & Technologies (QRT)'s Amgen position peaked at $333M in Q4 2024.
3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.